Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EPS (Weighted Average and Diluted): 2011-2024

Historic EPS (Weighted Average and Diluted) for Tenax Therapeutics (TENX) over the last 6 years, with Dec 2024 value amounting to -$1.15.

  • Tenax Therapeutics' EPS (Weighted Average and Diluted) rose 52.46% to -$6.38 in Q2 2013 from the same period last year, while for Apr 2013 it was -$6.87, marking a year-over-year increase of 52.39%. This contributed to the annual value of -$1.15 for FY2024, which is 96.30% up from last year.
  • As of FY2024, Tenax Therapeutics' EPS (Weighted Average and Diluted) stood at -$1.15, which was up 96.30% from -$31.04 recorded in FY2023.
  • Tenax Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at -$1.15 during FY2024, with a 5-year trough of -$31.04 in FY2023.
  • Over the past 2 years, Tenax Therapeutics' median EPS (Weighted Average and Diluted) value was -$16.09 (recorded in 2024), while the average stood at -$16.09.
  • Data for Tenax Therapeutics' EPS (Weighted Average and Diluted) shows a peak YoY surged of 96.30% (in 2024) over the last 5 years.
  • Tenax Therapeutics' EPS (Weighted Average and Diluted) (Yearly) stood at -$31.04 in 2023, then spiked by 96.30% to -$1.15 in 2024.